PLCB3 and non-small cell lung carcinoma: Elevated mRNA expression of PLCB3 was associated with the worse OS for every NSCLC patient (p = 0.00017, HR = 1.27, 95% CI = 1.12–1.45; Figure 9(a)) as well as AC patients (p = 6e−07, HR = 1.81, 95% CI = 1.43–2.29; Figure 9(b)).